CDK4 and breast cancer: Dysregulation of cyclin-dependent kinases (CDKs), mainly CDK4/6 and retinoblastoma protein (RB) pathway induces sustained cellular proliferation and has been associated with the pathogenesis of HR+ breast cancer [4].